Article
Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice.
The American journal of pathology - 1 Dec 2014
Banko Nicole S, McAlpine Cameron S, Venegas-Pino Daniel E, Raja Preeya, Shi Yuanyuan, Khan Mohammad I, Werstuck Geoff H
Abstract excerpt
Studies have implicated signaling through glycogen synthase kinase (GSK) 3α/β in the activation of pro-atherogenic pathways and the accelerated development of atherosclerosis. By using a mouse model, we examined the role of GSK3α in the development and progression of accelerated atherosclerosis. We crossed Gsk3a/GSK3α-knockout mice with low-density lipoprotein receptor (Ldlr) knockout mice. Five-week-old...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
